China SXT Pharmaceuticals, Inc. (SXTC) Net income 2017–2026
China SXT Pharmaceuticals, Inc. (SXTC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$6.2MFY2026 · since FY2017: $1.2M → -$6.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$6.2M | -87.8% |
| FY2025 | -$3.3M | -6.6% |
| FY2024 | -$3.1M | +47.8% |
| FY2023 | -$5.9M | -3.5% |
| FY2022 | -$5.7M | -108.7% |
| FY2021 | -$2.7M | +73.3% |
| FY2020 | -$10.3M | -768.4% |
| FY2019 | $1.5M | +29.6% |
| FY2018 | $1.2M | +0.2% |
| FY2017 | $1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice